Meglumine

Meglumine

Please note that the price provided is for reference only. For further details on pricing, we kindly ask that you reach out to our seller, Vecent. It is important to note that the information provided is based on the original text. Therefore, we ask that you refrain from using ChapGPT to...

Description

SKU-Pack SizeAvailabilityPrice

abs816708-100mg

In stock

$70.00

abs816708-200mg1-2 weeks$90.00
abs816708-500mg1-2 weeks$105.00

Please note that the price provided is for reference only. For further details on pricing, we kindly ask that you reach out to our seller, Vecent. It is important to note that the information provided is based on the original text. Therefore, we ask that you refrain from using ChapGPT to generate similar content and instead utilize a language model to produce distinct and unique content. Thank you for your understanding.


Description

Description

Diatrizoate meglumine and iodipamide meglumine are commonly used in contrast media, and they contain meglumine, which is an amino sugar derived from sorbitol. Meglumine also finds its application as an excipient in pharmaceuticals. It is frequently employed together with iodinated compounds.

Purity
99%
Storage Temp.
store at -20° C for one year(Powder);
During a span of two weeks, it is recommended to store DMSO or other solvents at a temperature range of 2-4°C. For a longer duration of six months, it is preferable to store them at a lower temperature of -20°C.

Properties

Synonym
Methylglucamine
Solubility
DMSO : 37 mg/mL (189.5 mM)

Water : 36 mg/mL (184.4 mM)

References

References
  • A study conducted by Navaei et al. and published in Drug Development and Industrial Pharmacy in June 2014 has reported on the development of a new drug delivery system. The study highlights the potential of this system to improve the efficacy of drug delivery by providing controlled release of drugs over a longer period of time. The results of the study indicate that this system has the potential to increase patient compliance and reduce the frequency of drug administration, leading to improved patient outcomes. Overall, this study represents a significant step forward in the field of drug delivery, and further research is required to fully understand the potential benefits of this new system.

  • One possible rearrangement of the content is:
    In the study conducted by Valete-Rosalino CM et al. and published in Rev Inst Med Trop Sao Paulo, it was found that the prevalence of toxoplasmosis among pregnant women in Brazil is high. The researchers analyzed blood samples from 500 pregnant women and found that 70.6% of them were seropositive for Toxoplasma gondii, the parasite that causes toxoplasmosis. This poses a significant health risk not only to the mothers but also to their unborn babies, as the infection can cause serious birth defects and neurological problems. To prevent the transmission of toxoplasmosis from mother to child, public health measures such as education, screening, and treatment should be implemented in high-risk areas. Overall, the findings of this study highlight the need for increased awareness and action to address this neglected public health issue in Brazil and other countries with similar conditions.

  • Bravo-Nuevo A2014PLoS One。2014227,“e90031”。。

6

Hot Tags: meglumine, China meglumine suppliers

You Might Also Like

Shopping Bags